Company information:
Dicerna Eu Limited (No: 09446220)
Address: SUITE 1, 7TH FLOOR, 50 BROADWAY, LONDON, SW1H 0BL, UNITED KINGDOM
Status: Active
Incorporated: 18-Feb-2015
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 03-Mar-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: TIMOTHY BERNSTEIN ( DOB: Apr-1981 From: Mar-2022 )
Current Director: BOB DALE BROWN ( DOB: Jul-1964 From: Mar-2022 )
Current Secretary: VISTRA REGISTRARS (UK) LIMITED ( From: Jul-2015 )
Resigned Director: JAMES DENTZER ( From: Feb-2015 To: Jan-2016 )
Resigned Director: DOUGLAS FAMBROUGH ( DOB: Jan-1967 From: Feb-2015 To: Mar-2022 )
Resigned Director: DOUGLAS PÀGAN ( DOB: Nov-1971 From: Jul-2020 To: Mar-2022 )
Resigned Director: JAMES BARRY WEISSMAN ( DOB: Feb-1962 From: Jan-2016 To: Mar-2022 )
Persons of Significant Control:
Dicerna Pharmaceuticals, Inc, 75, Hayden Avenue Lexington, Ma, 02421, Massachusetts, United States: Has significant influence or control (Notified: 2016-04-06)
Company Accounts Summary (£)
| Item | 2015 | 2016 | 2019 | 2020 | 2021 | 2022 | Chart |
|---|---|---|---|---|---|---|---|
| Net assets (liabilities) | -165,016 | -169,371 | -165016,-169371,0.0,0.0,0.0,0.0 | ||||
| Equity / share capital and reserves | -165,016 | -169,371 | -201,998 | -209,842 | -223,004 | -232,345 | -165016,-169371,-201998.0,-209842.0,-223004.0,-232345.0 |